Medication-assisted treatment (MAT) has transformed how opioid use disorder (OUD) is treated. One of the most important advances in recent years is injectable buprenorphine, a long-acting form of MAT designed to stabilize recovery without daily dosing.
At Phoenix Rising Recovery, injectable buprenorphine is used strategically—not automatically—as part of a comprehensive treatment plan focused on safety, stability, and long-term recovery.
This guide explains what injectable buprenorphine is, how it works, who it’s best for, and how it compares to other forms of buprenorphine.
What Is Injectable Buprenorphine?
Injectable buprenorphine is a long-acting formulation of buprenorphine, a partial opioid agonist used to treat opioid use disorder.
Unlike daily sublingual tablets or films, injectable buprenorphine is administered by a medical provider and releases medication gradually over time.
Two common long-acting formulations include:
- Monthly injections
- Weekly or extended-release injections (depending on formulation)
Once administered, the medication forms a depot under the skin, steadily releasing buprenorphine to maintain consistent blood levels.
How Buprenorphine Injections Works in the Brain
Buprenorphine works by:
- Partially activating opioid receptors (reducing cravings and withdrawal)
- Blocking stronger opioids like fentanyl or heroin
- Producing a “ceiling effect” that lowers overdose risk compared to full opioids
Because it is a partial agonist, buprenorphine provides stability without the intense euphoria associated with misuse.
Injectable forms enhance this effect by eliminating daily fluctuations in medication levels.
Why Injectable Buprenorphine Was Developed
Daily buprenorphine can be highly effective—but it also presents challenges for some patients, including:
- Missed doses
- Medication diversion
- Daily reminders of addiction
- Inconsistent blood levels
- Difficulty maintaining routine early in recovery
Injectable buprenorphine was designed to address these barriers by offering long-term receptor stability with less daily burden.
Key Benefits of Injectable Buprenorphine
1. Consistent Medication Levels
Long-acting injections maintain stable buprenorphine levels, which can reduce:
- Cravings
- Breakthrough withdrawal
- Mood fluctuations
2. No Daily Dosing
For many patients, removing daily medication decisions helps:
- Reduce relapse risk
- Improve adherence
- Support early recovery structure
3. Lower Diversion Risk
Because injections are administered by medical professionals, there is no take-home medication, reducing the risk of misuse or diversion.
4. Improved Treatment Engagement
Some patients find injectable buprenorphine allows them to:
- Focus more fully on therapy
- Rebuild routines
- Engage in work, family, and recovery activities
Who Is Injectable Buprenorphine Best For?
Injectable buprenorphine is not for everyone. It may be appropriate for individuals who:
- Have moderate to severe opioid use disorder
- Are already stabilized on buprenorphine
- Struggle with daily medication adherence
- Are at high risk of relapse or overdose
- Prefer fewer medication decisions during recovery
A medical evaluation is essential to determine appropriateness.
Who May Not Be a Good Candidate for the Buprenorphine Injection?
Injectable buprenorphine may not be appropriate for individuals who:
- Are not yet stabilized on buprenorphine
- Need flexible dose adjustments
- Have certain medical conditions
- Prefer short-acting formulations
- Are early in withdrawal or induction
At Phoenix Rising Recovery, MAT decisions are individualized—not protocol-driven.
Injectable vs. Sublingual Buprenorphine
| Feature | Injectable Buprenorphine | Sublingual Buprenorphine |
|---|---|---|
| Dosing | Weekly or monthly | Daily |
| Administration | Medical provider | Self-administered |
| Diversion risk | Very low | Higher |
| Flexibility | Lower | Higher |
| Blood level stability | Very stable | Variable |
Both options can be effective when used appropriately.
Side Effects and Safety Considerations of Buprenorphine Injections
Possible side effects include:
- Injection-site reactions
- Headache
- Nausea
- Constipation
- Fatigue
Because injectable buprenorphine remains in the body for weeks, side effects cannot be quickly reversed, which is why careful screening is important.
Injectable Buprenorphine and Overdose Risk
Buprenorphine lowers overdose risk compared to full opioids, but mixing it with alcohol, benzodiazepines, or other sedatives still carries danger.
Long-acting formulations also help protect against relapse-related overdose by maintaining opioid receptor coverage.
How Injectable Buprenorphine Fits Into Treatment at Phoenix Rising Recovery
Medication alone is not treatment. At Phoenix Rising Recovery, buprenorphine is combined with:
- Medically supervised detox (when needed)
- Trauma-informed therapy (CBT, DBT, EMDR)
- Mental-health treatment
- Relapse-prevention planning
- Aftercare and monitoring
Our goal is stability first, autonomy later, supporting patients as they rebuild independence safely.
Can Patients Taper Off Injectable Buprenorphine?
Yes. Injectable buprenorphine can be:
- Continued long-term
- Transitioned to sublingual forms
- Gradually tapered under medical supervision
There is no single “correct” duration. Treatment length depends on:
- History of use
- Relapse risk
- Mental health
- Social stability
When to Consider Treatment
If opioid use feels difficult to control, withdrawal drives continued use, or fentanyl exposure is a concern, early treatment can save lives.
Injectable buprenorphine may be one option, but the right plan starts with a comprehensive assessment.
A Final Word
Injectable buprenorphine represents a major advance in addiction treatment—but it works best as part of a whole-person recovery plan, not a stand-alone solution.
Phoenix Rising Recovery offers evidence-based MAT options tailored to today’s opioid landscape.
Frequently Asked Questions
What is injectable buprenorphine used for?
Injectable buprenorphine is used to treat opioid use disorder (OUD) by reducing cravings and withdrawal symptoms. It provides long-acting opioid receptor stabilization without the need for daily medication dosing.
How long does injectable buprenorphine last?
Depending on the formulation, injectable buprenorphine can last one week to one month per dose. The medication slowly releases under the skin, maintaining steady levels over time.
Is injectable buprenorphine the same as Suboxone?
No. Suboxone is a sublingual (under-the-tongue) medication taken daily and contains buprenorphine with naloxone. Injectable buprenorphine contains only buprenorphine and is administered by a medical provider on a scheduled basis.
Who is a good candidate for injectable buprenorphine?
Injectable buprenorphine may be appropriate for individuals who:
– Have stabilized on buprenorphine
– Struggle with daily medication adherence
– Are at higher risk of relapse or overdose
– Prefer fewer daily reminders of addiction
– A medical assessment is required to determine suitability.
Can injectable buprenorphine cause withdrawal?
Injectable buprenorphine itself does not cause withdrawal when taken as prescribed. However, stopping treatment abruptly or switching medications without supervision may lead to withdrawal symptoms.
Does injectable buprenorphine block fentanyl or heroin?
Buprenorphine binds strongly to opioid receptors and can block or reduce the effects of other opioids, including fentanyl and heroin. This receptor coverage helps lower relapse and overdose risk.
What are the side effects of injectable buprenorphine?
Buprenorphine binds strongly to opioid receptors and can block or reduce the effects of other opioids, including fentanyl and heroin. This receptor coverage helps lower relapse and overdose risk.
Is injectable buprenorphine safer than daily opioids?
Yes. Buprenorphine has a ceiling effect, meaning it produces less respiratory depression than full opioids. Injectable formulations further reduce risk by preventing missed doses and misuse.
Can someone overdose on injectable buprenorphine?
Overdose risk is significantly lower than with full opioids, but mixing buprenorphine with alcohol, benzodiazepines, or other sedatives can still be dangerous. Medical supervision is essential.
Can injectable buprenorphine be tapered off?
Yes. Patients can taper off injectable buprenorphine under medical supervision or transition to other forms of treatment. There is no fixed timeline—tapering decisions are based on stability and relapse risk.
Is injectable buprenorphine a long-term treatment?
It can be either short-term or long-term, depending on individual needs. Some patients use it during early recovery, while others benefit from longer maintenance.
Do you still need therapy if you’re on injectable buprenorphine?
Yes. Medication alone does not address the psychological, emotional, or behavioral drivers of addiction. Combining MAT with therapy significantly improves long-term recovery outcomes.
Sources
- U.S. Food & Drug Administration. (2024). Information about medications for opioid use disorder (MOUD). https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud
- National Institute on Drug Abuse. (2024). Medications to treat opioid use disorder. https://nida.nih.gov/research-topics/medications-opioid-use-disorder
- Substance Abuse and Mental Health Services Administration. (2024). Medications for substance use disorders. https://www.samhsa.gov/substance-use/treatment/options
- Substance Abuse and Mental Health Services Administration. (2023). Opioid treatment programs (OTPs). https://www.samhsa.gov/medications-substance-use-disorders/otp
- Centers for Disease Control and Prevention. (2024). Using medications to treat opioid use disorder. https://www.cdc.gov/overdose-prevention/hcp/clinical-care/medications-for-opioid-use-disorder.html
- Shulman, M., Wai, J. M., & Nunes, E. V. (2019). Buprenorphine treatment for opioid use disorder: An overview. Addiction Science & Clinical Practice, 14(44). https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-019-0160-
- American Society of Addiction Medicine. (2020). National practice guideline for the treatment of opioid use disorder. https://www.asam.org/quality-care/clinical-guidelines
- U.S. Food & Drug Administration. (2023). Brixadi (buprenorphine extended-release injection). https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/brixadi-buprenorphine